Investor Relations
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Latest Financial Results
Q1 2018
Quarter Ended Mar 31, 2018
Stock Information
Company Overview
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investor Contact Information
Company
Kane Biotech Inc.
162-196 Innovation Drive
Winnipeg, Manitoba R3T 2N2
Canada
T: 204.477.7592
ir@kanebiotech.com
Investor Relations
Edison Advisors
Tirth Patel
Vice President, Investor Relations
295 Madison Avenue, 18th Floor
New York, NY 10017
T: 646-653-7035
M: 386-295-2215
tpatel@edisongroup.com
Transfer Agent
Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1